BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 10514405)

  • 1. Establishment of a human thymic myoid cell line. Phenotypic and functional characteristics.
    Wakkach A; Poea S; Chastre E; Gespach C; Lecerf F; De La Porte S; Tzartos S; Coulombe A; Berrih-Aknin S
    Am J Pathol; 1999 Oct; 155(4):1229-40. PubMed ID: 10514405
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phenotypic and functional characterization of human thymic stromal cell lines.
    Wakkach A; Chastre E; Bruand C; Cohen-Kaminsky S; Emami S; Gespach C; Berrih-Aknin S
    Cell Mol Biol (Noisy-le-grand); 2001 Feb; 47(1):167-78. PubMed ID: 11292252
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thymic myoid cells express high levels of muscle genes.
    Mesnard-Rouiller L; Bismuth J; Wakkach A; Poëa-Guyon S; Berrih-Aknin S
    J Neuroimmunol; 2004 Mar; 148(1-2):97-105. PubMed ID: 14975590
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of acetylcholine receptor genes in human thymic epithelial cells: implications for myasthenia gravis.
    Wakkach A; Guyon T; Bruand C; Tzartos S; Cohen-Kaminsky S; Berrih-Aknin S
    J Immunol; 1996 Oct; 157(8):3752-60. PubMed ID: 8871679
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pathogenetic significance of fetal-type acetylcholine receptors on thymic myoid cells in myasthenia gravis.
    Geuder KI; Marx A; Witzemann V; Schalke B; Toyka K; Kirchner T; Müller-Hermelink HK
    Dev Immunol; 1992; 2(2):69-75. PubMed ID: 1643420
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acetylcholine receptors in human thymic myoid cells in situ: an immunohistological study.
    Schluep M; Willcox N; Vincent A; Dhoot GK; Newsom-Davis J
    Ann Neurol; 1987 Aug; 22(2):212-22. PubMed ID: 3662452
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of cytokines on acetylcholine receptor expression: implications for myasthenia gravis.
    Poëa-Guyon S; Christadoss P; Le Panse R; Guyon T; De Baets M; Wakkach A; Bidault J; Tzartos S; Berrih-Aknin S
    J Immunol; 2005 May; 174(10):5941-9. PubMed ID: 15879086
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human myoid cells protect thymocytes from apoptosis.
    Le Panse-Ruskoné R; Berrih-Aknin S
    Ann N Y Acad Sci; 2003 Sep; 998():266-9. PubMed ID: 14592883
    [No Abstract]   [Full Text] [Related]  

  • 9. IgG from "seronegative" myasthenia gravis patients binds to a muscle cell line, TE671, but not to human acetylcholine receptor.
    Blaes F; Beeson D; Plested P; Lang B; Vincent A
    Ann Neurol; 2000 Apr; 47(4):504-10. PubMed ID: 10762162
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thymic myoid cells as a myasthenogenic antigen and antigen-presenting cells.
    Matsumoto MY; Matsuo H; Oka T; Fukudome T; Hayashi K; Shiraishi H; Motomura M; Shibuya N; Ayabe H
    J Neuroimmunol; 2004 May; 150(1-2):80-7. PubMed ID: 15081251
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pathogenesis of myasthenia gravis. Acetylcholine receptor-related antigenic determinants in tumor-free thymuses and thymic epithelial tumors.
    Kirchner T; Tzartos S; Hoppe F; Schalke B; Wekerle H; Müller-Hermelink HK
    Am J Pathol; 1988 Feb; 130(2):268-80. PubMed ID: 2449082
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Myf5 and Myogenin in the development of thymic myoid cells - Implications for a murine in vivo model of myasthenia gravis.
    Hu B; Simon-Keller K; Küffer S; Ströbel P; Braun T; Marx A; Porubsky S
    Exp Neurol; 2016 Mar; 277():76-85. PubMed ID: 26708556
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A rapid, fluorescence-based assay for detecting antigenic modulation of the acetylcholine receptor on human cell lines.
    Keefe D; Hess D; Bosco J; Tzartos S; Powell J; Lamsa J; Josiah S
    Cytometry B Clin Cytom; 2009 May; 76(3):206-12. PubMed ID: 18825779
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A stromal myoid cell line provokes thymic T-cell immigration at the second and third gestational trimesters.
    Lambropoulou M; Tamiolakis D; Venizelos I; Alexiadis G; Limberis V; Galazios G; Tsikouras P; Karamanidis D; Koutsougeras G; Nikolaidou S; Petrakis G; Papadopoulos H; Papadopoulos N
    Rev Med Chir Soc Med Nat Iasi; 2007; 111(3):710-6. PubMed ID: 18293705
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reflections on the "intrathymic pathogenesis" of myasthenia gravis.
    Hohlfeld R; Wekerle H
    J Neuroimmunol; 2008 Sep; 201-202():21-7. PubMed ID: 18644632
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The thymus in myasthenia gravis. Changes typical for the human disease are absent in experimental autoimmune myasthenia gravis of the Lewis rat.
    Meinl E; Klinkert WE; Wekerle H
    Am J Pathol; 1991 Nov; 139(5):995-1008. PubMed ID: 1951638
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of the main immunogenic region of acetylcholine receptor in myasthenia gravis. An Fab monoclonal antibody protects against antigenic modulation by human sera.
    Tzartos SJ; Sophianos D; Efthimiadis A
    J Immunol; 1985 Apr; 134(4):2343-9. PubMed ID: 3973387
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Specific activation of lymphocytes against acetylcholine receptor in the thymus in myasthenia gravis.
    Fujii Y; Hashimoto J; Monden Y; Ito T; Nakahara K; Kawashima Y
    J Immunol; 1986 Feb; 136(3):887-91. PubMed ID: 2416838
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Distribution of molecules mediating thymocyte-stroma-interactions in human thymus, thymitis and thymic epithelial tumors.
    Marx A; Schömig D; Schultz A; Gattenlöhner S; Jung A; Kirchner T; Melms A; Müller-Hermelink HK
    Thymus; 1994; 23(2):83-93. PubMed ID: 7725387
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phenotypically diverse mouse thymic stromal cell lines which induce proliferation and differentiation of hematopoietic cells.
    Faas SJ; Rothstein JL; Kreider BL; Rovera G; Knowles BB
    Eur J Immunol; 1993 Jun; 23(6):1201-14. PubMed ID: 8500519
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.